🇺🇸 FDA

Drug profile · INN

sepiapterin

SEPHIENCE

approved A16AX28
US status
approved
Patents linked
2
News articles
0

Quick answer

sepiapterin (SEPHIENCE) is an FDA-listed pharmaceutical active ingredient. Associated with PTC THERAPEUTICS, INC.. Route of administration: oral. Current US regulatory status: approved.

Key facts

INN sepiapterin
Brand SEPHIENCE
Route ORAL
Formulation POWDER
ATC code A16AX28
Originator PTC THERAPEUTICS, INC.

Related patents

Search patents →

  1. US 9486456

    Treatment of esophageal motility disorder using sepiapterin, tetrahydrobiopterin and derivatives thereof

    Expires Mon Nov 03 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 8669258

    Treatment for gastroparesis using sepiapterin

    Expires Mon Mar 06 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is sepiapterin?

sepiapterin (SEPHIENCE) is an FDA-listed pharmaceutical active ingredient. Associated with PTC THERAPEUTICS, INC.. Route of administration: oral. Current US regulatory status: approved.

What is the brand name for sepiapterin?

SEPHIENCE is a marketed brand name for sepiapterin. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of sepiapterin?

sepiapterin has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.